- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02275000
Feasibility Study of Physiotherapy for Functional Motor Symptoms
Randomised Feasibility Study of a Physiotherapy Programme for Patients With Functional Motor Symptoms (FMS).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants will be recruited from outpatient neurology clinics at Queen Square. Those who consent to take part will complete baseline outcome measures (Time 1) before being randomised to either a Treatment as Usual control group or the Intervention group.
Treatment as Usual group -
- Participants will be directed to online patient information resources (www.neurosymptoms.org)
- Participants will be placed on the waiting list to be assessed for the inpatient treatment programme for functional symptoms at The National Hospital for Neurology and Neurosurgery. The waitlist is currently greater than 12 months.
- A referral is made to local community therapy services (which may include physiotherapy, occupational therapy and psychological therapy). If the participant has had contact from their community therapy services in the previous 12 months, a letter summarising the participant's diagnosis and physiotherapy needs will be sent.
- Participants will be asked to return at 4 weeks to complete outcome measures for a second time (Time 2)
A referral to community therapy for such patients is usual practice in the UK, although the form in which the community therapy is provided tends to be inconsistent across the UK. In most cases it will entail between 1 and 8 outpatient or domiciliary physiotherapy appointments. Some communities will have access to Occupational Therapy, which may entail supported practice and advice to increase independence with functional tasks and the provision of equipment. The provision of community therapy to participants will be monitored through the CSRI.
Intervention Group -
For participants allocated to the intervention group, a 5 day admission on the Day Hospital at the National Hospital for Neurology and Neurosurgery is arranged. The physiotherapy intervention will take place in the physiotherapy department. Participants will be admitted individually (and not in groups). Outside of physiotherapy times participants are encouraged to rest in the day hospital and complete a workbook. A single independent physiotherapist will be trained to deliver the intervention.
The participant (+/- family member) will attend an initial meeting with the consultant neurologist and the treating physiotherapist. The neurologist will perform a brief neurological assessment and confirm the diagnosis.
- The diagnosis will be explained again to the patient, using the word "functional" to describe the diagnosis.
- Physical signs of FMS will be demonstrated to the patient. This includes distractibility, Hoover's sign and entrainment.
- The treatment programme will be explained to the patient, linking resolution of symptoms with treatment rationale.
- The participant will attend 8-9 physiotherapy sessions over the 5 days. The intervention is a combination of education on functional motor symptoms, movement retraining and development of a self management plan.
- After the final physiotherapy session, the participant will complete the outcome measures (Time 2) and a feedback form.
Both groups will be followed up at 6 months after recruitment to the study (Time 3). An independent assessor will administer the outcome measures.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom, WC1N 3BG
- The National Hospital for Neurology and Neurosurgery
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- A clinically established diagnosis of functional motor symptoms according to the Fahn-Williams criteria.
- Diagnostic investigations have come to an end.
- The patient accepts the diagnosis of functional motor symptoms.
- Symptom duration of at least six months.
- Symptoms must be sufficient to cause significant distress (subjectively described by the patient) or impairment in social, occupational or other important areas of functioning.
Exclusion Criteria:
- Unable to understand English.
- Pain, fatigue or dissociative seizures is the predominant symptom.
- Prominent untreated axis 1 disorders (e.g. anxiety or depression).
- Level of disability prevents participation in a 5 day outpatient programme (Barthel Index score less than 25/100)
- Patient unable to attend 5 consecutive days.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
5 Day physiotherapy programme at the National Hospital for Neurology and Neurosurgery, Queen Square, London UK.
|
The experimental group will complete a 5 day physiotherapy programme consisting of education, movement retraining and a self management plan.
|
|
Active Comparator: Treatment as usual
Participants are referred to their local neuro-physiotherapy service and if appropriate placed on a waiting list for inpatient rehabilitation.
|
Treatment as usual physiotherapy.
The participant will be referred to their closest NHS outpatient neuro-physiotherapy service.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical Global Impression Scale of Change
Time Frame: Approximately 4 weeks after randomisation (this will be immediately after treatment for the experimental arm) and 6 months
|
Self rated 5 point Likert scale of change
|
Approximately 4 weeks after randomisation (this will be immediately after treatment for the experimental arm) and 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Short Form 36
Time Frame: Baseline and 6 months
|
Baseline and 6 months
|
|
|
Hospital Anxiety and Depression Scale
Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months
|
Baseline, approximately 4 weeks after randomisation and 6 months
|
|
|
EQ-5D-5L
Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months
|
Baseline, approximately 4 weeks after randomisation and 6 months
|
|
|
Brief Illness Perception Questionnaire
Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months
|
Baseline, approximately 4 weeks after randomisation and 6 months
|
|
|
Work and Social Adjustment Scale
Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months
|
Baseline, approximately 4 weeks after randomisation and 6 months
|
|
|
Disabilities of the Arm, Shoulder and Hand (DASH)
Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months
|
self reported questionnaire of upper limb function
|
Baseline, approximately 4 weeks after randomisation and 6 months
|
|
Functional Mobility Scale
Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months
|
Scale of assistance required when walking 5, 50 and 500 metres.
|
Baseline, approximately 4 weeks after randomisation and 6 months
|
|
Psychogenic Movement Disorders Rating Scale (PMDRS)
Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months
|
Blind video analysis of movement
|
Baseline, approximately 4 weeks after randomisation and 6 months
|
|
Berg Balance Scale
Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months
|
Baseline, approximately 4 weeks after randomisation and 6 months
|
|
|
10 metre Walk Test
Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months
|
timed walk over 10 metres
|
Baseline, approximately 4 weeks after randomisation and 6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Client Services Receipt Inventory (CSRI)
Time Frame: Baseline and 6 month follow up
|
This questionnaire collects retrospective information about the use of health and social care services, income, employment and benefits.
It can be used to calculate service costs and total costs of care.
|
Baseline and 6 month follow up
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Glenn Nielsen, UCL
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14/LO/0573
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Conversion Disorder
-
University Hospital, Basel, SwitzerlandRecruitingFunctional Neurological DisorderSwitzerland
-
University of Colorado, DenverRecruitingFunctional Neurological DisorderCanada
-
Western University, CanadaNot yet recruitingFunctional Movement DisorderCanada
-
Western University, CanadaNot yet recruitingFunctional Movement DisorderCanada
-
Medical University of GrazRecruitingFunctional Neurological Disorder | Functional Movement DisorderAustria
-
University Hospital, Clermont-FerrandRecruitingConversion Disorder in ChildrenFrance
-
Hospital Center Guillaume RégnierRecruitingFunctional Neurological Disorder | Motor FNDFrance
-
King's College LondonRecruitingFunctional Neurological DisorderUnited Kingdom
-
Swiss Paraplegic Research, NottwilCompletedParalysis | Functional Neurological Symptom Disorder | Conversion Disorder with Weakness/ParalysisSwitzerland
-
King's College LondonNot yet recruitingConversion Disorder | Functional Neurological Disorder | Functional Neurological Disorders | Conversion Disorder With Weakness/Paralysis
Clinical Trials on 5 Day Physiotherapy Programme
-
Hacettepe UniversityEnrolling by invitationKnee OsteoarthritisTurkey (Türkiye)
-
Blind Veterans UKUnknownFall | Visual Impairment | Accidental FallUnited Kingdom
-
University of ValenciaRecruitingMenopause | Postmenopausal Symptoms | Climacteric Syndrome | Perimenopausal DisorderSpain
-
University of TartuRecruitingAutism Spectrum Disorder | Attention Deficit Hyperactivity DisorderEstonia
-
University of MalagaFundación Pública Andaluza para la Investigación de Málaga en Biomedicina...Completed
-
Çankırı Karatekin UniversityRecruitingLow Back Pain | Intervertebral Disc Displacement | RadiculopathyTurkey
-
Canterbury Christ Church UniversityEast Kent Hospitals University NHS Foundation TrustCompletedChronic Low-back PainUnited Kingdom
-
Kantonsspital Winterthur KSWTerminatedPost Intensive Care Unit SyndromeSwitzerland
-
Charite University, Berlin, GermanyCompleted
-
Fakulti Sains KesihatanRecruiting